List of Tables
Summary Table: Global Market for Research Antibodies, by Application, Through 2025
Table 1: Most-Cited Antibodies and Their Suppliers, 2017
Table 2: Global Market for Research Antibodies, by Product, Through 2025
Table 3: Examples of Clinically Important Monoclonal Antibodies
Table 4: Global Market for Primary Antibodies, by Region, Through 2025
Table 5: Secondary Antibody Selection
Table 6: Global Market for Secondary Antibodies, by Region, Through 2025
Table 7: Global Market for Research Antibodies, by Clonality, Through 2025
Table 8: Global Market for Polyclonal Antibodies, by Region, Through 2025
Table 9: Global Market for Monoclonal Antibodies, by Region, Through 2025
Table 10: Global Market for Research Antibodies, by Major Reactivities, Through 2025
Table 11: Global Market for Anti-Human Antibodies, by Region, Through 2025
Table 12: Global Market for Anti-Mouse Research Antibodies, by Region, Through 2025
Table 13: Rat Antibodies with Different Isotypes.
Table 14: Global Market for Anti-Rat Research Antibodies, by Region, Through 2025
Table 15: Global Market for Research Antibodies, by Application, Through 2025
Table 16: Global Market for Western Blotting Applications, by Region, Through 2025
Table 17: Global Market for Flow Cytometry Applications, by Region, Through 2025
Table 18: Global Market for Immunohistochemistry (IHC) Applications, by Region, Through 2025
Table 19: Global Market for Immunohistochemistry (IHC) Applications, by Region, Through 2025
Table 20: Global Market for ELISA Applications, by Region, Through 2025
Table 21: Global Market for Research Antibodies, by Host Species, Through 2025
Table 22: Global Market for Rabbit Research Antibodies, by Region, Through 2025
Table 23: Global Market for Goat Research Antibodies, by Region, Through 2025
Table 24: Global Market for Mouse Research Antibodies, by Region, Through 2025
Table 25: Global Market for Sheep Research Antibodies, by Region, Through 2025
Table 26: Global Market for Donkey Research Antibodies, by Region, Through 2025
Table 27: Global Market for Other Host Species Research Antibodies, by Region, Through 2025
Table 28: Global Market for Research Antibodies, by End User, Through 2025
Table 29: Global Market for Research Antibodies in Universities/Academic Institutions, by Region, Through 2025
Table 30: Global Market for Research Antibodies in Pharma/Biotech Companies, by Region, Through 2025
Table 31: Global Market for Research Antibodies in Other End Users, by Region, Through 2025
Table 32: Global Market for Research Antibodies, by Region, Through 2025
Table 33: U.S. Grants for Research, by Type of Cancer, 2017
Table 34: North American Market for Research Antibodies, by Product, Through 2025
Table 35: North American Market for Research Antibodies, by Clonality, Through 2025
Table 36: North American Market for Research Antibodies, by Major Reactivities, Through 2025
Table 37: North American Market for Research Antibodies, by Application, Through 2025
Table 38: North American Market for Research Antibodies, by Host Species, Through 2025
Table 39: North American Market for Research Antibodies, by End User, Through 2025
Table 40: North American Market for Research Antibodies, by Country, Through 2025
Table 41: Estimated New Cancer Cases in Males in Canada, 2017
Table 42: Estimated New Cancer Cases in Females in Canada, 2017
Table 43: European Market for Research Antibodies, by Product, Through 2025
Table 44: European Market for Research Antibodies, by Clonality, Through 2025
Table 45: European Market for Research Antibodies, by Major Reactivities, Through 2025
Table 46: European Market for Research Antibodies, by Application, Through 2025
Table 47: European Market for Research Antibodies, by Host Species, Through 2025
Table 48: European Market for Research Antibodies, by End Users, Through 2025
Table 49: European Market for Research Antibodies, by Country, Through 2025
Table 50: Deaths Caused by Cardiovascular Disease Compared with Other Causes of Death in Germany, Percent Change 2005–2016
Table 51: Diseases Causing the Greatest Number of Premature Deaths in Germany, Percentage Change from 2005-2016
Table 52: Asia-Pacific Market for Research Antibodies, by Product, Through 2025
Table 53: Asia-Pacific Market for Research Antibodies, by Clonality, Through 2025
Table 54: Asia-Pacific Market for Research Antibodies, by Major Reactivities, Through 2025
Table 55: Asia Pacific Market for Research Antibodies, by Application, Through 2025
Table 56: Asia-Pacific Market for Research Antibodies, by Host Species, Through 2025
Table 57: Asia-Pacific Market for Research Antibodies, by End User, Through 2025
Table 58: Asia-Pacific Market for Research Antibodies, by Country, Through 2025
Table 59: Incidence of All Cancers in Australia, by Sex, 2017
Table 60: Rest of World Market for Research Antibodies, by Product, Through 2025
Table 61: Rest of World Market for Research Antibodies, by Clonality, Through 2025
Table 62: Rest of World Market for Research Antibodies, by Major Reactivities, Through 2025
Table 63: Rest of World Market for Research Antibodies, by Application, Through 2025
Table 64: Rest of World Market for Research Antibodies, by Host Species, Through 2025
Table 65: Rest of World Market for Research Antibodies, by End User, Through 2025
Table 66: Rest of World Market for Research Antibodies, by Country/Region, Through 2025
Table 67: U.S. FDA-approved Monoclonal Antibodies in the Market
Table 68: Global Distribution of Antibody Suppliers, by Region, 2018
Table 69: Distribution of Antibody Suppliers in the U.S., by State, 2017
Table 70: Antibody Therapeutics Granted First Approvals in The European Union or The United States During, 2018
Table 71: Abcam: Product Portfolio
Table 72: Absolute Antibody Ltd.: Product Portfolio
Table 73: Agilent Technologies Inc.: Product Portfolio
Table 74: BD Biosciences: Product Portfolio
Table 75: Beckman Coulter Inc.: Product Portfolio
Table 76: Bio-Rad: Product Portfolio
Table 77: Bio-Techne: Product Portfolio
Table 78: Cell Signaling Technology: Product Portfolio,by Type
Table 79: Cell Signaling Technology: Products Portfolio, by Source
Table 80: Jackson ImmunoResearch Laboratories: Product Portfolio
Table 81: Merck KGaA: Product Portfolio
Table 82: Rockland Immunochemical Inc.: Product Portfolio
Table 83: Santa Cruz Biotechnology Inc.: Product Portfolio
Table 84: Sino Biological: Product Portfolio
Table 85: Thermo Fisher Scientific: Product Portfolio
Table 86: United States Biological: Product Portfolio
Table 87: United States Biological: Product Portfolio
Table 88: Acronyms Used in this Report
List of Figures
Summary Figure: Global Market Shares for Research Antibodies, by Application, 2019
Figure 1: Global Market Shares for Research Antibodies, by Product, 2019
Figure 2: Global Market Shares for Research Antibodies, by Product, 2025
Figure 3: Global Market for Primary Antibodies, 2018–2025
Figure 4: Global Market for Primary Antibodies, by Region, 2018–2025
Figure 5: Global Market for Secondary Antibodies, 2018–2025
Figure 6: Global Market for Secondary Antibodies, by Region, 2018–2025
Figure 7: Global Market Shares for Research Antibodies, by Clonality, 2019
Figure 8: Global Market Shares for Research Antibodies, by Clonality, 2025
Figure 9: Global Market for Polyclonal Antibodies, 2018–2025
Figure 10: Global Market for Polyclonal Antibodies, by Region, 2018–2025
Figure 11: Global Market for Monoclonal Antibodies, 2018–2025
Figure 12: Global Market for Monoclonal Antibodies, by Region, 2018–2025
Figure 13: Global Market Shares for Research Antibodies, by Major Reactivities, 2019
Figure 14: Global Market Shares for Research Antibodies, by Major Reactivities, 2025
Figure 15: Global Market for Anti-Human Research Antibodies, 2018–2025
Figure 16: Global Market for Anti-Human Research Antibodies, by Region, 2018–2025
Figure 17: Global Market for Anti-Mouse Research Antibodies, 2018–2025
Figure 18: Global Market for Anti-Mouse Research Antibodies, by Region, 2018–2025
Figure 19: Global Market for Anti-Rat Research Antibodies, 2018–2025
Figure 20: Global Market for Anti-Rat Research Antibodies, by Region, 2018–2025
Figure 21: Global Market Shares for Research Antibodies, by Application, 2019
Figure 22: Global Market Shares for Research Antibodies, by Application, 2025
Figure 23: Global Market for Western Blot Applications, 2018–2025
Figure 24: Global Market for Western Blotting Applications, by Region, 2018–2025
Figure 25: Global Market for Flow Cytometry Applications, 2018–2025
Figure 26: Global Market for Flow Cytometry Applications, by Region, 2018–2025
Figure 27: Estimated New Cases of Leukemia, Lymphoma and Myeloma, 2020
Figure 28: Global Market for Immunohistochemistry (IHC) Applications, 2018–2025
Figure 29: Global Market for Immunohistochemistry (IHC) Applications, by Region, 2018–2025
Figure 30: Global Market for Immunohistochemistry (IHC) Applications, 2018–2025
Figure 31: Global Market for Immunohistochemistry (IHC) Applications, by Region, 2018–2025
Figure 32: Global Market for ELISA Applications, 2018–2025
Figure 33: Global Market for ELISA Application Segment, by Region, 2018–2025
Figure 34: Global Market Shares for Research Antibodies, by Host Species, 2019
Figure 35: Global Market Shares for Research Antibodies, by Host Species, 2025
Figure 36: Number of Rabbits used in Research, Testing and Teaching in the U.S., 2012–2018
Figure 37: Global Market for Rabbit Research Antibodies, 2018–2025
Figure 38: Global Market for Rabbit Research Antibodies, by Region, 2018–2025
Figure 39: Global Market for Goat Research Antibodies, 2018–2025
Figure 40: Global Market for Goat Research Antibodies, by Region, 2018–2025
Figure 41: Global Market for Mouse Research Antibodies, 2018–2025
Figure 42: Global Market for Mouse Research Antibodies, by Region, 2018–2025
Figure 43: Global Market for Sheep Research Antibodies, 2018–2025
Figure 44: Global Market for Sheep Research Antibodies, by Region, 2018–2025
Figure 45: Global Market for Donkey Research Antibodies, 2018–2025
Figure 46: Global Market for Donkey Research Antibodies, by Region, 2018–2025
Figure 47: Global Market for Other Host Species Research Antibodies, 2018–2025
Figure 48: Global Market for Other Host Species Research Antibodies, by Region, 2018–2025
Figure 49: Global Market Shares for Research Antibodies, by End User, 2019
Figure 50: Global Market Shares for Research Antibodies, by End User, 2025
Figure 51: Global Incidence of Patients with Chronic Diseases, 2005–2030
Figure 52: Global Market for Research Antibodies in Universities/Academic Institutions, 2018–2025
Figure 53: Global Market for Research Antibodies in Universities/Academic Institutions, by Region, 2018–2025
Figure 54: Global Market for Research Antibodies in Pharma/Biotech Companies, 2018–2025
Figure 55: Global Market for Research Antibodies in Pharma/Biotech Companies, by Region, 2018–2025
Figure 56: Global Market for Research Antibodies in Other End Users, 2018–2025
Figure 57: Global Market for Research Antibodies in Other End Users, by Region, 2018–2025
Figure 58: Global Market Shares for Research Antibodies, by Region, 2019
Figure 59: Global Market Shares for Research Antibodies, by Region, 2025
Figure 60: North American Market Shares for Research Antibodies, by Product, 2019
Figure 61: North American Market Shares for Research Antibodies, by Clonality, 2019
Figure 62: North American Market Shares for Research Antibodies Market, by Major Reactivities, 2019
Figure 63: North American Market Shares for Research Antibodies, by Application, 2019
Figure 64: North American Market Shares for Research Antibodies, by Host Species, 2019
Figure 65: North American Market Shares for Research Antibodies, by End User, 2019
Figure 66: North American Market Shares for Research Antibodies, by Country, 2019
Figure 67: U.S. Market for Research Antibodies, 2018–2025
Figure 68: Canadian Market for Research Antibodies, 2018–2025
Figure 69: Mexican Market for Research Antibodies, 2018–2025
Figure 70: European Market Shares for Research Antibodies, by Product, 2019
Figure 71: European Market Shares for Research Antibodies, by Clonality, 2019
Figure 72: European Market Shares for Research Antibodies, by Major Reactivities, 2019
Figure 73: European Market Shares for Research Antibodies, by Application, 2019
Figure 74: European Market Shares for Research Antibodies, by Host Species, 2019
Figure 75: European Market Shares for Research Antibodies, by End User, 2019
Figure 76: European Market Shares for Research Antibodies, by Country, 2019
Figure 77: German Market for Research Antibodies, 2018–2025
Figure 78: French Market for Research Antibodies, 2018–2025
Figure 79: Health Spending and Financing in France, 2005–2018
Figure 80: Market Demand for Medical Equipment in France, 2015–2017
Figure 81: U.K. Market for Research Antibodies, 2018–2025
Figure 82: Italian Market for Research Antibodies, 2018–2025
Figure 83: Spanish Market for Research Antibodies, 2018–2025
Figure 84: Rest of European Market for Research Antibodies, 2018–2025
Figure 85: Asia-Pacific Market Shares for Research Antibodies, by Product, 2019
Figure 86: Asia-Pacific Market Shares for Research Antibodies, by Clonality, 2019
Figure 87: Asia-Pacific Market Shares for Research Antibodies, by Major Reactivities, 2019
Figure 88: Asia-Pacific Market Shares for Research Antibodies, by Application, 2019
Figure 89: Asia-Pacific Market Shares for Research Antibodies, by Host Species, 2019
Figure 90: Asia-Pacific Market Shares for Research Antibodies, by End User, 2019
Figure 91: Asia-Pacific Market Shares for Research Antibodies, by Country, 2019
Figure 92: Japanese Market for Research Antibodies, 2018–2025
Figure 93: Chinese Market for Research Antibodies, 2018–2025
Figure 94: Indian Market for Research Antibodies, 2018–2025
Figure 95: Australian and New Zealand Market for Research Antibodies, 2018–2025
Figure 96: Rest of Asia-Pacific Market for Research Antibodies, 2018–2025
Figure 97: Rest of the World Market Shares for Research Antibodies, by Product, 2019
Figure 98: Rest of the World Market Shares for Research Antibodies, by Clonality, 2019
Figure 99: Rest of the World Market Shares for Research Antibodies, by Major Reactivities, 2019
Figure 100: Rest of the World Market Shares for Research Antibodies, by Application, 2019
Figure 101: Rest of the World Market Shares for Research Antibodies, by Host Species, 2019
Figure 102: Rest of the World Market Shares for Research Antibodies Major Reactivities, by End User, 2019
Figure 103: Rest of the World Market Shares for Research Antibodies, by Country/Region, 2019
Figure 104: Brazilian Market for Research Antibodies, 2018–2025
Figure 105: GCC Countries Market for Research Antibodies, 2018–2025
Figure 106: Rest of World Countries Market for Research Antibodies, 2018–2025
Figure 107: Impact of COVID-19 on the Pharmaceutical/Biotech Industry
Figure 108: Value Chain Analysis
Figure 109: Global Market Ranking of Research Antibodies, by Manufacturer, 2019
Figure 110: Abcam: Annual Revenue, 2018–2020
Figure 111: Agilent Technologies Inc.: Annual Revenue, 2016–2020
Figure 112: Agilent Technologies Inc.: Revenue Shares, by Region, 2019
Figure 113: Agilent Technologies Inc.: Revenue Shares, by Business Segments, 2020
Figure 114: BD Biosciences: Annual Revenue, 2016–2019
Figure 115: BD Biosciences: Revenue Shares, by Region, 2019
Figure 116: BD Biosciences: Revenue Shares, by Business Segments, 2020
Figure 117: Bio-Rad: Annual Revenue, 2016–2019
Figure 118: Bio-Rad: Revenue Shares, by Region, 2019
Figure 119: Bio-Rad: Revenue Shares, by Business Unit, 2019
Figure 120: Bio-Techne: Annual Revenue, 2016–2019
Figure 121: Bio-Techne: Revenue Shares, by Region, 2019
Figure 122: Bio-Techne: Revenue Shares, by Business Segment, 2019
Figure 123: Merck KGaA: Annual Revenue, 2016–2019
Figure 124: Merck KGaA: Revenue Shares, by Region, 2019
Figure 125: Merck KGaA: Revenue Shares, by Investment, 2019
Figure 126: Thermo Fisher Scientific: Annual Revenue, 2016–2019
Figure 127: Thermo Fisher Scientific: Revenue Shares, by Region, 2019
Figure 128: Thermo Fisher Scientific: Revenue Shares, by Business Segments, 2019
